UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
This piece explains what sequence of returns risk is in retirement, why it matters for retirement income, and how to interpret its effects on portfolios.
26,789 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Goldman Sachs raises Enphase Energy's price target to 57 and maintains a Buy rating, highlighting a nascent rebound i...
Actor Niko Foster has placed a 14,000-square-foot Nevada mansion on the market for $22 million, spotlighting Strip vi...
Take-Two is set to release Q4 results as GTA VI heads toward a highly anticipated November debut. The company plans a...
Eating out is a daily ritual for many families. This guide shows you how to choose credit card dining rewards that ac...
Charles Hoskinson pivots back to Cardano as Midnight winds toward a close after a $250 million investment in Wyoming....
A Reagan Institute survey shows two-thirds of voters are upbeat on American-led innovation, spanning parties and gene...
Senator Cynthia Lummis warns that failing to advance the CLARITY Act could push U.S. crypto policy toward a regulator...
Palantir faces a steeper path in 2026 as the stock retreats, yet bulls argue the core AI platform and government dema...
ServiceNow climbs as investors chase AI-driven growth in enterprise software, with Dell's recent results helping lift...
A fresh BEA release shows the U.S. consumer draining savings while income grows slowly, signaling trouble ahead for g...
Powell, who stepped down earlier this month, warned that politicizing the Fed could erode its credibility. Investors ...